-- Amgen's successful advances in cancer diagnostics -- Google enters the field of enterprise searching -- GeneGo launches its first in a series of disease-specific software tools, this one for cystic fibrosis -- An MIT study analyzes the global aspects of clinical trials -- Federal agencies start a National Toxicology Program aimed at reducing reliance on animal testingAbout Bio-IT World Bio-IT World (www.bio-itworld.com), the flagship publication of Cambridge Healthtech Institute (CHI), is the leading source of news on technology and strategic innovation in drug discovery, development, and clinical trials. Bio-IT World explores the tools and results of predictive biology as the industry adapts to the new world of personalized medicine. Bio-IT World has won 34 national and regional awards, more than any other magazine covering the life sciences industry. CHI offers a suite of published resources through a new division -- Cambridge Healthtech Media Group -- that includes Bio-IT World magazine, numerous topic-specific eNewsletters, white papers, webcasts, podcasts, conferences, and the Bio-IT World Best Practices Awards. The magazine is based in Needham, MA. About Cambridge Healthtech Institute Founded in 1992, Cambridge Healthtech Institute (www.healthtech.com) is the industry leader offering the preeminent source of information to the leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications, and eNewsletters, CHI's portfolio of products includes Cambridge Healthtech Institute Events, Pharmaceutical Strategy Series, Insight Pharma Reports, Marketing Services, and Cambridge Healthtech Media Group.
Contact Information: Contact: Kevin Davies (Editor-in-Chief, Bio-IT World) 781-972-1341